Adial Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MANCHESTER CAPITAL MANAGEMENT LLC | 08/14/2023 | 1.20 M | $250,351 | 0.00% | 4.54% |
| VANGUARD GROUP INC | 08/14/2023 | 203,358 | $42,339 | 0.00% | 0.77% |
| BLACKROCK INC. | 08/11/2023 | 194,364 | $40,467 | -13.94% | 0.73% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/11/2023 | 180,285 | $37,499 | -18.89% | 0.68% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/11/2023 | 137,464 | $28,592 | 0.00% | 0.52% |
| RENAISSANCE TECHNOLOGIES LLC | 08/11/2023 | 107,100 | $22,000 | 6.14% | 0.40% |
| STATE STREET CORP | 08/14/2023 | 52,354 | $10,890 | 0.00% | 0.20% |
| TRUIST FINANCIAL CORP | 08/01/2023 | 33,862 | $7,050 | 0.00% | 0.13% |
| NORTHERN TRUST CORP | 08/11/2023 | 29,705 | $6,185 | 0.00% | 0.11% |
| VIRTU FINANCIAL LLC | 07/27/2023 | 26,473 | $6,000 | -42.44% | 0.10% |
| ADVISOR GROUP HOLDINGS, INC. | 08/21/2023 | 24,046 | $4,998 | 3.00% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 08/14/2023 | 20,691 | $4,308 | -57.56% | 0.08% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2023 | 17,623 | $3,669 | -0.47% | 0.07% |
| ENVESTNET ASSET MANAGEMENT INC | 08/04/2023 | 13,088 | $2,725 | 0.00% | 0.05% |
| CREATIVE PLANNING | 07/21/2023 | 10,000 | $2,082 | 100.00% | 0.04% |
| MORGAN STANLEY | 08/14/2023 | 535 | $111 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/15/2023 | 187 | $39 | -79.65% | 0.00% |
| BROWN ADVISORY INC | 07/31/2023 | 0 | $0 | -100.00% | 0.00% |
| EMPIRICAL FINANCIAL SERVICES, LLC D.B.A. EMPIRICAL WEALTH MANAGEMENT | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
Adial Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Adial Pharmaceuticals, Inc.. The most heavily invested institutionals were:
American Portfolios Advisors: 5,500
LADENBURG THALMANN FINANCIAL SERVICES INC.: 10,394
8.52% of Adial Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15,894 shares in the last 24 months. This purchase volume represents approximately $17,324 in transactions.